Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”

Схожие документы

• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
  по: Gautret, Philippe, et al.
  Опубликовано: (2021)
• Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
  по: dos Santos, Marcelo Rodrigues
  Опубликовано: (2021)
• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
  по: Gautret, Philippe, et al.
  Опубликовано: (2020)
• Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
  по: Wambier, Carlos Gustavo
  Опубликовано: (2021)
• Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
  по: Toumi, Mondher, et al.
  Опубликовано: (2020)